Home  /  Resource Library  /  Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma

Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma

Results of a study investigating pegaspargase combined with sintilimab for first line treatment of ENKTL.